NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, OR INTO OR FROM CANADA, JAPAN OR AUSTRALIA.
This announcement is an advertisement and not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in the Company or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.
14 MAY 2010
PLACING OF ORDINARY SHARES, ADMISSION TO TRADING ON AIM AND FIRST DAY OF TRADING
Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, is pleased to announce that admission of its ordinary shares to trading on AIM (“Admission”) will take place today. Nomura Code Securities Limited (“Nomura Code”) is acting as Nominated Adviser and Broker to the Company. The Company has raised £5.2 million before expenses through the issue of 10,147,059 Placing Shares at 51 pence per share. On Admission, the Company will have 36,569,359 Ordinary Shares in issue and a market capitalisation of approximately £18.7 million.
DETAILS OF THE PLACING AND IPO
The Company raised gross proceeds of approximately £5.2 million (net proceeds of approximately £4.4 million) from the Placing which will be used to fund the further development of identified materials for the energy, electronics and biomedical sectors. The products resulting from these materials are expected to generate significant revenues from (1) milestones and royalties resulting from the licensing of the materials being developed under existing joint development programmes with the Company’s partners and for which "proof of concept" has been demonstrated; and (2) through direct biomedical product sales
The Placing comprises the issue of 10,147,059 Placing Shares at 51 pence per share together with 10,147,059 Placing Warrants
The Enlarged Issued Ordinary Share Capital at Admission will be 36,569,359 Ordinary Shares, giving the Company an expected market capitalisation of £18.7 million at Admission
Admission to trading on AIM and commencement of dealings are expected to take place at 8:00a.m. on Friday, 14 May 2010 under the ticker "IKA". The Company is expected to be listed in the Alternative Energy sector.
A copy of the Company’s Admission Document is available at http://www.ilika.com/MEDIA/ilika_plc_admission_document.pdf.
BACKGROUND TO ILIKA
Ilika is an advanced materials company which accelerates the discovery of new and patentable materials using its unique high throughput technologies (‘‘HTT’’) process for identified end uses in the energy, electronics and biomedical sectors. This process enables hundreds of scalable materials to be made in a single, automated operation and subsequently tested for key properties.
Traditionally, materials development has been a slow and arduous task, with manual, sequential methods used to make samples of material that are then tested for suitability. On average, it takes between 7 and 10 years to move from an initial discovery through to the first commercial prototype.
Experiments carried out by the Company can be executed 10 to 100 times faster than using traditional techniques.
Graeme Purdy, Chief Executive of Ilika plc, commented:
"We are delighted by the strong support new and existing shareholders have shown for developing the business through an AIM listing. Ilika is already generating revenues from its own two successful biomedical products and has a pipeline of materials partnered with large multinational companies. Today marks the beginning of a new phase in the Company’s development, where its technology will help meet the need for advanced new materials, particularly in the energy and electronic industries."
For further information, see www.ilika.com
Tel. +44 (0) 23 8011 1400
Graeme Purdy, Chief Executive
Steve Boydell, Finance Director
Nomura Code Securities Limited
Tel. +44 (0) 20 7776 1200
Pelham Bell Pottinger
Tel. +44 (0) 20 7337 1509